Philip T. Sager

11.3k total citations · 4 hit papers
142 papers, 7.7k citations indexed

About

Philip T. Sager is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Philip T. Sager has authored 142 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Cardiology and Cardiovascular Medicine, 41 papers in Surgery and 28 papers in Molecular Biology. Recurrent topics in Philip T. Sager's work include Cardiac electrophysiology and arrhythmias (80 papers), Cardiac Arrhythmias and Treatments (44 papers) and Lipoproteins and Cardiovascular Health (24 papers). Philip T. Sager is often cited by papers focused on Cardiac electrophysiology and arrhythmias (80 papers), Cardiac Arrhythmias and Treatments (44 papers) and Lipoproteins and Cardiovascular Health (24 papers). Philip T. Sager collaborates with scholars based in United States, United Kingdom and Sweden. Philip T. Sager's co-authors include Norman Stockbridge, Gary A. Gintant, Börje Darpö, William G. Stevenson, T Nebout, Leslie A. Saxon, Isaac Wiener, Holly R. Middlekauff, Enrico P. Veltri and Leslie Lipka and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Philip T. Sager

137 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.

1993 600 citations Philip T. Sager et al. profile →
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia

2003 506 citations Lorenzo Melani, Leslie Lipka et al. profile →
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

2013 386 citations Philip T. Sager, Gary A. Gintant et al. American Heart Journal profile →
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

2016 303 citations Gary A. Gintant, Jennifer Pierson et al. profile →

Peers

Countries citing papers authored by Philip T. Sager

Since Specialization

Citations

This map shows the geographic impact of Philip T. Sager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip T. Sager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip T. Sager more than expected).

Fields of papers citing papers by Philip T. Sager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip T. Sager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip T. Sager. The network helps show where Philip T. Sager may publish in the future.

Co-authorship network of co-authors of Philip T. Sager

This figure shows the co-authorship network connecting the top 25 collaborators of Philip T. Sager. A scholar is included among the top collaborators of Philip T. Sager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip T. Sager. Philip T. Sager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CE-482905-001 SELF-ADMINISTERED ETRIPAMIL NASAL SPRAY RAPIDLY TERMINATED SPONTANEOUS PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT): ANALYSIS OF OPEN-LABEL TREATMENT IN THE RAPID STUDY 2024 ·Heart Rhythm ·Bruce S. Stambler, (unknown), Marco Alings, Paul Dorian, Hein Heidbüchel, Jaco H. Houtgraaf, Peter R. Kowey, José Luís Merino, (unknown), Jonathan P. Piccini, Sean D. Pokorney, Philip T. Sager, Atul Verma, (unknown), David B. Bharucha, Francis Plat, (unknown), Michael Chen, James E. Ip	0
2	An overview of drug‐induced sodium channel blockade and changes in cardiac conduction: Implications for drug safety 2024 ·Clinical and Translational Science ·Khuram W. Chaudhary, Colleen E. Clancy, Pei‐Chi Yang, Jennifer Pierson, Alan L. Goldin, John Koerner, Todd Wisialowski, Jean‐Pierre Valentin, John P. Imredy, Armando Lagrutta, Simon Authier, Robert Kleiman, Philip T. Sager, (unknown), Michael K. Pugsley	5
3	Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it 2021 ·Cardiovascular Research ·Stanley Nattel, Philip T. Sager, Jörg Hüser, Jordi Heijman, Dobromir Dobrev	32
4	Scientific white paper on concentration-QTc modeling 2017 ·Journal of Pharmacokinetics and Pharmacodynamics ·Christine Garnett, Peter L. Bonate, Qianyu Dang, Georg Ferber, (unknown), Jiang Liu, Devan V. Mehrotra, Steve Riley, Philip T. Sager, Christoffer W. Tornøe, Yaning Wang	170
5	The Cardiac Safety Research Consortium enters its second decade: An invitation to participate 2016 ·American Heart Journal ·J. Rick Turner, Peter R. Kowey, Ignacio Rodríguez, Christopher H. Cabell, Gary A. Gintant, Cynthia L. Green, Barbara Kunz, (unknown), Philip T. Sager, Norman Stockbridge, Theressa J. Wright, John K. Finkle, Mitchell W. Krucoff	6
6	Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects 2016 ·Journal of Antimicrobial Chemotherapy ·Börje Darpö, Philip T. Sager, Prabhavathi Fernandes, Brian Jamieson, (unknown), Meijian Zhou, David Oldach	11
7	Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block 2016 ·PLoS ONE ·José Vicente, Lars Johannesen, (unknown), Jay W. Mason, Philip T. Sager, Esther Pueyo, David G. Strauss	29
8	Novel oral anticoagulants and reversal agents: Considerations for clinical development 2015 ·American Heart Journal ·Troy C. Sarich, Jonathan Seltzer, Scott D. Berkowitz, James C. Costin, John T. Curnutte, C. Michael Gibson, Maureane Hoffman, Edvardas Kaminskas, Mitchell W. Krucoff, Jerrold H. Levy, Paul D. Mintz, Paul Reilly, Philip T. Sager, Daniel E. Singer, Norman Stockbridge, Jeffrey I. Weitz, Peter R. Kowey	59
9	A Double-Blind, Randomized, Parallel, Placebo-Controlled Study Examining the Effect of Cross-Linked Polyelectrolyte in Heart Failure Patients with Chronic Kidney Disease 2012 ·European Journal of Heart Failure ·Maria Rosa Costanzo, J. Thomas Heywood, Barry M. Massie, Julie Iwashita, Lee W. Henderson, (unknown), Hamayak Sisakian, Hamlet Hayrapetyan, Philip T. Sager, Dirk J. van Veldhuisen, Detlef Albrecht	14
10	The Cardiac Safety Research Consortium electrocardiogram warehouse: Thorough QT database specifications and principles of use for algorithm development and testing 2010 ·American Heart Journal ·Paul Kligfield, Cynthia L. Green, (unknown), Philip T. Sager, Norman Stockbridge, Michael Li, Joanne Zhang, (unknown), Ignacio Rodríguez, Daniel M. Bloomfield, Mitchell W. Krucoff	22
11	Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug‐induced torsades de pointes 2008 ·British Journal of Pharmacology ·Philip T. Sager	30
12	Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia 2007 ·Journal of clinical lipidology ·Evan A. Stein, Leiv Ose, Kjetil Retterstøl, Serena Tonstad, (unknown), Susan S. Harris, Philip T. Sager	22
13	Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline 2006 ·The Journal of Clinical Pharmacology ·Börje Darpö, T Nebout, Philip T. Sager	260
14	Heterozygous familial hypercholesterolemia: Coadministration of ezetimibe plus atorvastatin 2003 ·Journal of the American College of Cardiology ·W.J.H. Vermaak, Xavier Pintó, (unknown), Philip T. Sager, Leslie Lipka, Ramachandran Suresh, Enrico P. Veltri	8
15	Ezetimibe coadministered with atorvastatin compared to atorvastatin alone in the attainment of low-density lipoprotein goals among high-risk patients with hypercholesterolemia 2003 ·Journal of the American College of Cardiology ·Evan A. Stein, Steen Stender, Pedro Mata, (unknown), Lorenzo Melani, Philip T. Sager, (unknown), Ramachandran Suresh, Enrico P. Veltri	1
16	Clinical Cardiac Electrophysiology Fellowship Teaching Objectives for the New Millennium 2001 ·Journal of Cardiovascular Electrophysiology ·Mark S. Link, Charles Antzelevitch, Albert L. Waldo, Augustus O. Grant, John Dimarco, M E Josephson, Francis E. Marchlinski, Hasan Garan, Philip T. Sager, David W. Reynolds, P Denes, Melvin M. Scheinman, N.A. Mark Estes	3
17	Modulation of antiarrhythmic drug effects by beta-adrenergic sympathetic stimulation 1998 ·The American Journal of Cardiology ·Philip T. Sager	13
18	Entrainment Techniques for Mapping Atrial and Ventricular Tachycardias 1995 ·Journal of Cardiovascular Electrophysiology ·William G. Stevenson, Philip T. Sager, (unknown)	104
19	Effects of amiodarone, sematilide, and sotalol on QT dispersion 1994 ·The American Journal of Cardiology ·Guanggen Cui, Luyi Sen, Philip T. Sager, (unknown), Bramah N. Singh	105
20	A prospective evaluation of the immediate reproducibility of the signal-averaged ECG 1991 ·American Heart Journal ·Philip T. Sager, (unknown), M J Espinosa Pascual, (unknown), Shahbudin H. Rahimtoola, Anil K. Bhandari	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact